Orifarm Generics A/S: vundne offentlige udbud

Ifølge tildelingsbekendtgørelser i TED har Orifarm Generics A/S vundet 15 udbud hos danske ordregivere med en samlet oplyst værdi på 1.952.898.726 kr.. Den seneste tildeling er dateret 4. november 2026.

UdbudOrdregiverVindereVærdiDato
Amgros 2027 2.1290.bAmgros I/SEQL Pharma AB, Sandoz A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Sandoz A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Teva Denmark A/S, Strides Nordic ApS, Sandoz A/S, Strides Nordic ApS, Zentiva Denmark ApS, Sandoz A/S, Teva Denmark A/S, Zentiva Denmark ApS, Strides Nordic ApS, Zentiva Denmark ApS, Orifarm A/S, 2care4 ApS19.962.664 kr.4. november 2026
Amgros 2027 2.290.bAmgros I/SOrifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, EQL Pharma AB, 2care4 ApS, 2care4 ApS, Abcur AB, 2care4 Generics ApS, Orifarm A/S, Abcur AB, Norgine Danmark A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, STADA Nordic ApS, Orifarm Generics A/S, 2care4 Generics ApS, 2care4 Generics ApS46.249.452 kr.25. oktober 2026
Amgros 2027 2.290.bAmgros I/SOrifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, EQL Pharma AB, 2care4 ApS, 2care4 ApS, Abcur AB, 2care4 Generics ApS, Orifarm A/S, Abcur AB, Norgine Danmark A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, STADA Nordic ApS, Orifarm Generics A/S, 2care4 Generics ApS, 2care4 Generics ApS46.249.452 kr.25. oktober 2026
Amgros 2027 2.290.bAmgros I/SOrifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, EQL Pharma AB, 2care4 ApS, 2care4 ApS, Abcur AB, 2care4 Generics ApS, Orifarm A/S, Abcur AB, Norgine Danmark A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, STADA Nordic ApS, Orifarm Generics A/S, 2care4 Generics ApS, 2care4 Generics ApS46.249.452 kr.25. oktober 2026
Amgros 2027 2.690.bAmgros I/SSandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag102.193.408 kr.25. oktober 2026
Amgros 2027 2.690.bAmgros I/SSandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag102.193.408 kr.25. oktober 2026
Amgros 2027 2.690.bAmgros I/SSandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag102.193.408 kr.25. oktober 2026
Amgros 2027 2.690.bAmgros I/SSandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag102.193.408 kr.25. oktober 2026
Amgros 2027 2.690.bAmgros I/SSandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag102.193.408 kr.25. oktober 2026
Amgros 2027 2.690.bAmgros I/SSandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag102.193.408 kr.25. oktober 2026
Amgros 2027 1.1202.aAmgros I/SMacure Pharma ApS, B. Braun Medical A/S, Orifarm Generics A/S, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Aguettant Nordic ApS, Orifarm A/S, STADA Nordic ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Øresund Pharma ApS, Sun Pharmaceuticals Germany GmbH381.745.570 kr.21. oktober 2026
Amgros 2027 2.1201.aAmgros I/SParanova Danmark ApS, Paranova Danmark ApS, Orifarm Generics A/S, Pfizer ApS, Gedeon Richter Plc, Orifarm A/S, Orifarm Generics A/S, XGX Pharma ApS, XGX Pharma ApS, Orifarm A/S, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, FrostPharma AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, FrostPharma AB128.202.512 kr.20. oktober 2026
Amgros 2027 2.1201.aAmgros I/SParanova Danmark ApS, Paranova Danmark ApS, Orifarm Generics A/S, Pfizer ApS, Gedeon Richter Plc, Orifarm A/S, Orifarm Generics A/S, XGX Pharma ApS, XGX Pharma ApS, Orifarm A/S, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, FrostPharma AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, FrostPharma AB128.202.512 kr.20. oktober 2026
Amgros 2027 1.700.aAmgros I/SMacure Pharma ApS, Swedish Orphan Biovitrum AB, Swedish Orphan Biovitrum AB, Orifarm Generics A/S, Recordati AB, Viatris ApS, Orifarm A/S, Ferring Lægemidler A/S, Orifarm A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Orion Pharma A/S, Orion Pharma A/S, Ferring Lægemidler A/S, Orifarm A/S, Viatris ApS, AstraZeneca A/S, AstraZeneca A/S, FrostPharma AB, FrostPharma AB, Sanofi A/S, BioMarin International Limited, Takeda Pharma A/S, BioMarin International Limited, Chiesi Pharma AB, Øresund Pharma ApS, Takeda Pharma A/S, Viatris ApS, Øresund Pharma ApS419.427.587 kr.12. oktober 2026
Amgros 2027 1.703.bAmgros I/SFerring Lægemidler A/S, Recordati AB, Norgine Danmark A/S, Sandoz A/S, Strides Nordic ApS, Norgine Danmark A/S, Orifarm Generics A/S, Norgine Danmark A/S123.449.077 kr.12. oktober 2026

Datakilde: TED © Den Europæiske Union. Tildelingsbekendtgørelser fra danske ordregivere.

Vinderbadge til din hjemmeside

Repræsenterer du Orifarm Generics A/S? Kopiér koden og indsæt den på jeres hjemmeside. Badget linker til denne side.

Forhåndsvisning:

🏆 Orifarm Generics A/S har vundet offentlige udbud – se udbuddene på EU-udbud.dk